ClinicalTrials.gov
public full text
Public Domain
Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction#916832
- Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin#256831
- Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin#18526
- Non-invasive Brain Stimulation to Enhance Treatment of Dysarthria Post-stroke#832909
- Data Management and Sharing Plan for: Repurposing metformin, an inhibitor of the unfolded protein response, as a treatment for food allergy.#260746
Record · ID 230370
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive